Various aspects of the present disclosure relate generally to apparatuses and methods for delivering powdered agents. More specifically, the present disclosure relates to apparatuses and methods for the endoscopic delivery of hemostatic powders.
When bleeding occurs in a subject's body during a medical procedure, a user performing the procedure may seek ways in which to reduce or to eliminate the bleeding. One way to manage bleeding is by applying a hemostatic powder at a site of the bleeding. Where the medical procedure being performed is an endoscopic procedure, applying the hemostatic powder at the site may entail delivering the powder to the site using a catheter. Ensuring that the hemostatic powder can be properly delivered to the site through the catheter may lead to improved outcomes.
Aspects of the present disclosure relate to, among other things, apparatuses and methods for delivering powdered agents. Each of the aspects disclosed herein may include one or more of the features described in connection with any of the other disclosed aspects.
In one example, an apparatus for delivering a powdered agent into a subject's body may include a first passage for receiving a pressurized gas. The apparatus also may include a container housing a powdered agent. The container may be in fluid connection with the first passage. At least a portion of the pressurized gas may be introduced into the powdered agent in the container to fluidize the powdered agent. The apparatus also may include a second passage for receiving the powdered agent from the container. In a first configuration of the apparatus, the second passage may not be in fluid connection with the container. In a second configuration of the apparatus, the second passage may be in fluid connection with the container. The apparatus may be configured to transition between the first configuration and the second configuration.
Any example of the apparatuses for delivering a powdered agent into a subject's body described herein may additionally or alternatively include one or more of the features below. The container may include a longitudinal axis, at least one wall, and at least one blade disposed between the longitudinal axis and the wall. The container may have a longitudinal axis. The second passage may have a longitudinal axis. The longitudinal axis of the second passage may be parallel to or coaxial with the longitudinal axis of the container. The longitudinal axes of the container and the second passage may be coaxial. The second passage may extend into the container. The apparatus may include at least one helical groove and at least one protrusion movably disposed within the at least one helical groove. The at least one protrusion may move in the at least one helical groove during a transition between the first configuration and the second configuration. The apparatus may include a protrusion configured to prevent the passage of the powdered agent from the container to the second passage when the apparatus is in the first configuration. The second passage may comprise an opening. At least a portion of the protrusion may be inside the opening when the apparatus is in the first configuration. The protrusion may extend from a top wall of the container. The container may comprise a movable cap. The apparatus may transition from the first configuration to the second configuration upon twisting of the cap.
In another example, a method for providing a powdered agent to a target site may include delivering the powdered agent to the target site using an apparatus including a powder chamber housing the powdered agent, a catheter, and a chassis coupled to the powder chamber and the catheter. Delivering the powdered agent may include fluidizing the powdered agent by directing a flow of pressurized gas into the powdered agent. Delivering also may include transitioning the apparatus from a first configuration to a second configuration. The powder chamber and the catheter may not be in fluid connection in the first configuration and may be in fluid connection in the second configuration. Delivering also may include directing the fluidized powdered agent into the catheter. Delivering also may include emitting the fluidized powdered agent from a distal end of the catheter to the target site.
Any method described herein may include one or more of the features or steps described below. Rotating at least a portion of the powder chamber relative to the chassis. The powder chamber may include at least one helical groove and at least one protrusion movably disposed within the at least one helical groove. Rotating at least a portion of the powder chamber may cause the at least one protrusion to move within the at least one helical groove. In the second configuration, fluidized powdered agent may be able to enter a passage fluidly connecting the powder chamber to the catheter. The passage may be a tube extending into the powder chamber.
In yet another example, an apparatus for delivering a powdered agent into a subject's body may include a powder chamber housing the powdered agent and a chassis in fluid connection with the powder chamber. The chassis may include a first passage for receiving the powdered agent from the powder chamber. The chassis also may include a second passage in fluid connection with the first passage. The second passage may receive the powdered agent from the first passage for exiting the chassis. The apparatus also may include at least one agitator on at least one of the powder chamber and the chassis. The at least agitator may include at least one of a piston, an eccentric weight, a motor, a reed, or a pulsating valve.
Any apparatus for delivering a powdered agent into a subject's body may additionally or alternatively include one or more of the features described below. The chassis may further comprise a trigger and at least one gear. Depression of the trigger may cause movement of the at least one gear. The at least one gear may cause movement of a piston, such that the piston strikes a surface of the chassis. The chassis may further include a rotatable member having at least one trough for receiving the powdered agent and delivering the powdered agent to the first passage. The at least one trough may be helical.
It may be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed. As used herein, the terms “comprises,” “comprising,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. The term “exemplary” is used in the sense of “example,” rather than “ideal.”
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate aspects of the present disclosure and together with the description, serve to explain the principles of the disclosure.
The present disclosure is drawn generally to apparatuses and methods for delivering powdered agents, and more specifically to apparatuses and methods for the endoscopic delivery of hemostatic powders. Reference now will be made in detail to aspects of the present disclosure, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts. The term “distal” refers to a portion farthest away from a user when introducing an instrument into a subject. By contrast, the term “proximal” refers to a portion closest to the user when placing the instrument into the subject. Though the following description refers to “endoscope” or “endoscopy,” the principles/aspects described herein may be used with any suitable introduction sheath or device, even if such sheath or device fails to include one or more features typically associated with “endoscopes.” It may be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the features claimed. Further, as used herein, the terms “comprises,” “comprising,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not necessarily include only those elements, but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. The term “exemplary” is used in the sense of “example,” rather than “ideal.” The terms “substantially,” “approximately” and “about” refer to a variation of plus or minus ten percent with respect to a stated value. The present embodiments disclosed herein may be used independently or in combination with one or more other disclosed embodiments.
During use with a subject (e.g., a patient), chassis 12, gas supply 14, and powder chamber 16 may remain outside of the subject, while catheter 18 may enter into the subject through, for example, an endoscope or other introducer sheath (not shown). In one contemplated use, catheter 18 may be inserted through the endoscope or sheath to position a distal end 20 of catheter 18 at or near a site of bleeding in the subject. The fluidized powdered agent may be emitted from the distal end 20 to the site to reduce or stop the bleeding.
Gas supply 14 may include, for example, a gas line 22. Gas line 22 may include a flexible length of tubing. A proximal end of gas line 22 may be coupled to a pressurized gas source (not shown), and a distal end of gas line 22 may be coupled to chassis 12, thereby creating a path for the pressurized gas to flow from the pressurized gas source to chassis 12. The pressurized gas source may include, for example, a pump device, a wall access in a hospital room, a canister, a manually-operated pump, a foot pedal-operated pump, and/or any other suitable pressurized gas source. Gas line 22 may be fixedly attached or removably attached to chassis 12 and/or the pressurized gas source.
Powder chamber 16 may include any suitable receptacle for holding powdered agent 54. Powder chamber 16 may include, for example, a substantially rigid vessel, such as a bottle. Alternatively, powder chamber 16 may include a substantially flexible vessel, such as a bag. Powder chamber 16 may have a closed end 24 and an open end 26 (
Powder chamber 16 may be fixedly attached or removably attached to chassis 12. Where powder chamber 16 is fixedly attached to chassis 12, reloading chassis 12 with powdered agent 54 may include removing a cap, cover, or the like from powder chamber 16, and pouring powdered agent 54 into powder chamber 16. Additionally or alternatively, reloading may entail switching out one or more components of chassis along with powder chamber 16. Where powder chamber 16 is removably attached to chassis 12, reloading chassis 12 with powdered agent 54 may include removing an empty powder chamber 16 from chassis 12, and coupling a full powder chamber 16 to chassis 12. Powder chamber 16 may be removably attached to chassis 12 by screw-type engagement, snap-fit engagement, friction fit engagement, and/or any other suitable form of attachment.
Catheter 18 may include a tubular length of medical grade material, and may have a proximal end with a proximal opening (not visible) and distal end 20 with a distal opening 30. The proximal end of catheter 18 may be coupled to chassis 12. Catheter 18 may include a lumen 28 extending therethrough from the proximal opening to distal opening 30. Fluidized powdered agent 54 from chassis 12 may flow through lumen 28 on its way to being emitted from distal opening 30. Catheter 18 may be sufficiently rigid to maintain its shape when inserted into the subject's body. Alternatively, catheter 18 may be sufficiently flexible to bend and conform to passages in the subject's body. Catheter 18 may be fixedly or removably attached to chassis 12.
Chassis 12 may include an inlet or port 32 to which gas line 22 may be coupled, an inlet or port 34 to which powder chamber 16 may be coupled, and an outlet or port 36 to which catheter 18 may be coupled. Chassis 12 may include a mixing chamber 38 that may be in fluid connection with inlet 32, inlet 34, and outlet 36. During use, the pressurized gas from gas line 22 may enter mixing chamber 38 via inlet 32, and powdered agent 54 may enter mixing chamber 38 via inlet 34. The pressurized gas and powdered agent 54 may mix in mixing chamber 38, producing fluidized powdered agent 54 that then exits from mixing chamber 38 and enters catheter 18 via outlet 36. Powdered agent 54 may be fluidized in that the pressurized gas may be introduced into powdered agent 54, resulting in the formation of a part-gas and part-solid medium having properties and characteristics of a fluid, such as a liquid.
Chassis 12 also may include a handle 40 for gripping by the user, and a trigger 42 for managing the flow of fluidized powdered agent 54. For example, trigger 42 may be operatively coupled to one or more valves (not shown) in one or more of inlet 32, inlet 34, mixing chamber 38, and outlet 36, to control the flow of one or more of the pressurized gas, powdered agent 54, and the fluidized powdered agent 54. Additionally or alternatively, trigger 42 may activate one or more actuators in apparatus 10 for facilitating fluidization of powdered agent 54. Exemplary actuators are described in the paragraphs below.
Mixing chamber 38 may be fixedly attached or removably attached to the rest of chassis 12. The removable attachment may be provided by any suitable mechanical attachment mechanism, such as by snap-fit engagement, friction fit, a latching mechanism, or the like. The removable attachment may allow the user to swap out one mixing chamber for another.
Passage 52 may include portions having different widths or diameters. For example, passage 52 may include a first portion 60 and a second portion 62. First portion 60 may be wider than second portion 62. The width, or diameter, of first portion 60 may be designed to receive open end 26 of powder chamber 16. Second portion 62, including its width or diameter, may be designed to control a rate of flow of powdered agent 54 into junction 55. Powder chamber 16 and passage 52 may be positioned above junction 55 such that gravity may assist with moving powdered agent 54 down from powder chamber 16 and passage 52 into junction 55.
In the example shown in
Piston 67 may be actuated to move when it is desired that powdered agent 54 be delivered. For example, piston 67 may move when trigger 42 is depressed. The action of piston 67 may agitate mixing chamber 64, powder chamber 16, or another component of chassis 12 and/or apparatus 10. Such agitation may result in powdered agent 54 moving through a portion of apparatus 10 such as open end 26, opening 50, and/or passage 52. It is contemplated that, due to the consistency and repeatability of the movements of piston 67, a predetermined amount of powdered agent 54 may be dispensed into junction 55 and/or passage 52 based on operation of piston 67. The predetermined amount may be set by adjusting, for example, a frequency of actuator 63, and/or a force applied by actuator 63 on rod 65 and piston 67.
Weight 72 may move relative to apparatus 10. Weight 72 may be configured to move when it is desired that powdered agent 54 be delivered. For example, weight 72 may move when trigger 42 is depressed. Any suitable actuator (not shown), such as a motor, turbine, or other suitable rotational drive, may spin weight 72. The actuator may be powered by the pressurized gas from line 22 and/or a mechanical or electrical power source. Weight 72 may spin on a rotational axis 73. Weight 72, and due to its eccentricity, may agitate mixing chamber 70, powder chamber 16, or another component of chassis 12 and/or apparatus 10. Such agitation may result in powdered agent 54 moving more readily through apparatus 10.
Motor 76 may be configured to operate when it is desired that powdered agent 54 be delivered. For example, motor 76 may operate when trigger 42 is depressed. The operation of motor 76 may cause motor 76 to vibrate, resulting in agitation of mixing chamber 74, powder chamber 16, and/or another component of chassis 12 and/or apparatus 10. Such agitation may result in powdered agent 54 moving more fluidly through apparatus 10.
Reed 82 may have a longitudinal axis. Reed 82 may be located at least partially in, for example, opening 46, passage 48, passage 56, and/or opening 58 of mixing chamber 80. Reed 82 may have a longitudinal axis and may be aligned such that a longitudinal axis of reed 82 is parallel to a longitudinal axis of passage 48 and/or passage 56. In the alternative, a longitudinal axis of reed 82 may be disposed at an angle relative to a longitudinal axis of passage 48 and/or passage 56. A longitudinal axis of reed 82 may align with the center of, for example, opening 46, passage 48, passage 56, and/or opening 58. In the alternative, a longitudinal axis of reed 82 may be disposed off-center with respect to a longitudinal axis of, for example, opening 46, passage 48, passage 46, and/or opening 58. Reed 82 may be secured in the desired location by any suitable mechanism (not depicted). It is contemplated that one end of reed 82 may be secured, while the opposite end of reed 82 may be free to move when exposed to a current of pressurized gas.
Reed 82 may be disposed so that pressurized gas passing through opening 46 may flow around reed 82, causing reed 82 to oscillate or otherwise vibrate. The movement of reed 82 may cause turbulence in the flow of gas through, for example, opening 46, passage 48, passage 56, or opening 58. The movement of reed 82 may also agitate one or more components of apparatus 10, including chassis 12, mixing chamber 80, and/or powder chamber 16. Such turbulence and/or vibration may facilitate the movement of powdered agent 54 through apparatus 10.
Mechanism 91 may be configured to transition between an open state and a closed state. For example, mechanism 91 may slide back and forth along an axis perpendicular to the axis of passage 52. Mechanism 91 may also be configured so that mechanism 91 may transition between an open state where a plane of mechanism 91 is perpendicular to an axis of passage 52, and a closed state where a plane of mechanism 91 is parallel to an axis of passage 52, or is at another angle relative to an axis of passage 52. For example, mechanism 91 may include a door configured to swing on a hinge. Mechanism 91 may be configured so as to, in a first configuration, cover open end 26 or opening 50, and in a second configuration, leave open end 26 or opening 50 open. Mechanism 91 may transition between the open and closed states by way of, for example, any suitable sliding mechanism or a hinge.
Mechanism 91 may be configured to be in the open and/or closed states for a predetermined amount of time. For example, mechanism 91 may be configured to be in the open state for a predetermined amount of time to allow a predetermined amount of powdered agent 54 to pass by mechanism 91. Mechanism 91 may also be configured to rapidly transition between the open state and the closed state. Such a rapid transition may be optimized for passage of powdered agent 54 past mechanism 91. The transition of mechanism 91 between the open state and the closed state may agitate mixing chamber 90, powder chamber 16, chassis 12, and/or another component of apparatus 10. Such agitation may result in powdered agent 54 moving through a portion of apparatus 10 such as open end 26, opening 50, and/or passage 52. Additionally or alternatively, mechanism 91 may engage packed bodies of powdered agent 54, and break them apart, as it moves between the open and closed states. As with the other configurations disclosed herein, the configuration of
As shown in
Mixing chamber 94 may include metering device 92. Metering device 92 may be rotatably received in a hole in mixing chamber 94. Metering device 92 may have a longitudinal axis which is parallel or substantially parallel to passages 98 and 106, and/or perpendicular or substantially perpendicular to passage 102. Metering device 92 may be configured so as to pass through passage 102 or to pass between passage 102 and junction 104. Metering device 92 may include one or more recesses or cavities, including, for example, alcoves 110. Alcoves 110 may be of a number of shapes, as discussed in further detail below.
In operation, metering device 92 may be rotated about its central longitudinal axis so that alcoves 110 also rotate around the central longitudinal axis of metering device 92. Alcoves 110 may be below powder chamber 16 and/or opening 100 so that powdered agent 54 may flow into an alcove 110. As the metering device 92 rotates, one alcove 110 may rotate toward the bottom of mixing chamber 94 and another alcove 110 may rotate toward the top of mixing chamber 94. Thus, an amount of powdered agent 54 may enter alcove 110 that is rotated toward the top. Once metering device 92 has been rotated further, bringing the powdered agent 54 containing alcove 110 toward the bottom of mixing chamber 94, gravity may cause the powdered agent in alcove 110 to fall or otherwise move from alcove 110 to junction 104 or passage 106. Meanwhile, powdered agent 54 may flow into another alcove 110 of metering device 92 that has been brought to the top by the rotation of metering device 92. Thus, turning of metering device 92 may facilitate repeatable dispensing of a predetermined amount of powdered agent 54, corresponding to the volume of alcove 110 and the speed of rotation of metering device 92, into junction 104 or passage 106. Metering device 92 may therefore aid in dispensing a predetermined amount of powdered agent 54 out of opening 108 and/or may assist in developing an even flow of powdered agent 54 out of opening 108.
As shown in
Chassis 112 may include an inlet or port 120 (which may be the same as or similar to inlet or port 32) to which gas line 118 may be coupled. Chassis 112 may receive mixing chamber 94, or any of the other mixing chambers described herein. Mixing chamber 94 may be in fluid connection with inlet 120. During use, the pressurized gas from gas line 118 may enter mixing chamber 94 via inlet 120. Pressurized gas and powdered agent 54 may mix in mixing chamber 94, producing fluidized powdered agent 54 that then exits from mixing chamber 94.
Chassis 112 also may include a handle 122 (which may be the same as or similar to handle 40) for gripping by the user, and a trigger 124 (which may be the same as or similar to trigger 42) for managing the flow of fluidized powdered agent 54. Mixing chamber 94 may be fixedly attached or removably attached to the rest of chassis 112.
Metering device 92 may pass through chassis 112, for example near inlet or port 120. Metering device 92 may include a handle or knob 126 by which metering device 92 may be rotated. Alternatively, metering device 92 may include components (e.g., any suitable actuator) allowing for automatic rotation of metering device 92.
Mixing chamber 146 may include an opening 148 and a passage 150 for the pressurized gas. Mixing chamber 146 also may include an opening 152 and a passage 154 for powdered agent 54. Passage 150 and passage 154 may meet at a junction 156, where the pressurized gas may be introduced into powdered agent 54, thereby fluidizing powdered agent 54. Mixing chamber 146 also may include a passage 158 and an opening 160 for fluidized powdered agent 54.
Chassis 142 may include a trigger 144. Trigger 144 may be the same as or similar to trigger 42 and may manage the flow of fluidized powdered agent 54. Trigger 144 may engage one or more gears. For example, depression of trigger 144 may cause movement of one or more gears 164. Gear 164 may, for example, be a straight gear (e.g., a gear rack) configured to move along a linear path. Alternatively, gear 164 may be a round gear or a gear of any other shape. Gear 164 may interact with one or more other gears 166. Gear 166 may be, for example, a round gear configured to rotate about a rotational axis. Alternatively, gear 166 may be of any other shape. Additional gears may also interact with gears 164 and 166.
The movement of gears 164 and/or 166 may actuate one or more pistons 168. Piston 168 may be the same or similar to piston 67. Depression of trigger 144 and/or movement of gears 164 and/or 166 may cause movement of a crown of one or more pistons 168. A piston 168 may be any type of piston which may move so as to strike a surface of apparatus 140. For example, a crown of piston 168 may strike a surface of a recess or cavity 169, or a housing (not shown) similar to component 68 of
The action of piston 168 may agitate mixing chamber 146, powder chamber 16, or another component of apparatus 140. Such agitation may result in powdered agent 54 moving more easily through apparatus 140. Piston 168, chassis 142, and mixing chamber 146 may be configured to dispense a predetermined amount of powdered agent 54 based on the frequency of movement, and/or the force of movement, of piston 168.
Trigger 144, gear 164 and/or gear 166 may be configured so that, upon release of trigger 144, trigger 144, gear 164, and/or gear 166 will return to the position they were in prior to depression of trigger 144. For example, one or more springs (not shown), or other suitable biasing members, may be used to return trigger 144, gear 164, and/or gear 166 to their rest positions. The return of trigger 144, gear 164, and/or gear 166 to their rest positions may be damped.
Powder chamber 190 may include any suitable receptacle for holding powdered agent 54. Powder chamber 190 may include, for example, a substantially rigid vessel, such as a bottle. Powder chamber 190 may be fixedly attached or removably attached to any suitable chassis, such as chassis 12 or any other aforementioned chassis. In
As shown in
Powder chamber 190 may include a base or wider portion 174. Wider portion 174 may serve as a gripping portion for a user to rotate powder chamber 190. Mixing chamber 171 may include a passage 176 for directing pressurized gas into powder chamber 190. Mixing chamber 171 may also include an opening 180 and a passage 182, wherein passage 182 may direct fluidized powdered agent 54 to opening 180 and out of mixing chamber 171.
Assembly 170 may also include passage 194. Passage 194 may include a top opening 196. Passage 194 may be in fluid connection with passage 182. Passage 194 may have a longitudinal axis which is coaxial with, or parallel to, a longitudinal axis of powder chamber 190. Powder chamber 190 may also include a protrusion 198 extending downwardly from a top portion of an outer wall 200. Protrusion 198 may have a lower portion 202 with a cross section narrower than opening 196. Protrusion 198 may taper so that an upper portion 204 of protrusion 198 has a cross section wider than opening 196. Protrusion 198 may be aligned with passage 194 so that lower portion 202 of protrusion 198 may enter passage 194 via opening 196, thereby plugging opening 196, either partially or fully depending on the depth of insertion of lower portion 202 into passage 194, to put assembly 170 in the closed position (
One or more curved surfaces a top portion of powder chamber 190, in conjunction with the tapering surfaces of protrusion 198, may funnel or otherwise facilitate flow of fluidized powder agent 54 toward a central longitudinal axis of powder chamber 190, and toward opening 196 of passage 194. For example, the curved surfaces and the tapering surfaces of protrusion 198 may form a portion of a toroid. Side walls of powder chamber 190 may be tapered, such that powder chamber gets narrower as it extends upward, to help direct fluidized powder agent 54 into passage 194.
It also is contemplated that assembly 170 may have a plurality of open positions that allow different levels of flow of fluidized powdered agent 54 through passage 194. For example, the greater the distance between protrusion 198 and opening 196, the greater the flow of fluidized powdered agent 154 into opening 196. Decreasing the distance may reduce the flow, while still allowing flow at the reduced level.
In one example, inner ring 224 of fluid randomizer 220 may extend concentrically around passage 194. An inner surface of inner ring 224 may be in contact with an outer surface of passage 194. Additionally or alternatively, outer ring 226 of fluid randomizer 222 may extend about an interior surface of powder chamber 190. An outer surface of outer ring 226 may be in contact with the interior surface of powder chamber 190. It is contemplated that inner ring 224 may be fixedly coupled to passage 194, and/or outer ring 226 may be fixedly coupled to the interior surface of powder chamber 190. Alternatively, inner ring 224 may be movably (e.g., slidably) coupled to passage 194, and/or outer ring 226 may be movably (e.g., slidably) coupled to the interior surface of powder chamber 190, allowing fluid randomizer 220 to move (e.g., rotate and/or rise and fall) within powder chamber 190. Movement of fluid randomizer 220 may be driven by the pressurized gas entering powder chamber 190 via opening 192.
An outer sleeve 240 may be disposed concentrically around and encompassing passage 232. For example, an inner surface of outer sleeve 240 may abut an outer surface of passage 232. Outer sleeve 240 may be made of the same or different material from passage 232. Outer sleeve 240 may be, for example, a hypotube. Outer sleeve 240 may have perforations or voids 244. Perforations 244 may have any of the qualities of perforations 236, described above. In the alternative, perforations 244 may have different qualities (such as shape or size) from perforations 236. Perforations 244 may be on locations of outer sleeve 240 which correspond to the locations of perforations 236 on passage 232. For example, perforations 244 may be located at the same height as perforations 236, and the spacing between perforations 244 may be proportional to the spacing between perforations 236. Perforations 244 may be the same size as perforations 232 or a different size from perforations 232. For example, perforations 244 may be larger than perforations 232.
One or both of passage 232 and outer sleeve 240 may be rotatable around a longitudinal axis of passage 232 and/or outer sleeve 240. For example, passage 232 and/or outer sleeve 240 may be rotatable by rotating powder chamber 190 to rotate one of passage 232 and outer sleeve 240 relative to the other, via engagement between protrusion 198 and passage 232 or outer sleeve 240; by sliding an actuator coupled to one of passage 232 and outer sleeve 240, to thereby rotate one of passage 232 and outer sleeve 240 relative to the other, with the actuator being accessible from an exterior of mixing chamber 181, or by any other suitable mechanism. The actuator may be coupled, for example, to an inner rotational member 246 of mixing chamber 181, which also may be coupled to one of passage 232 and outer sleeve 240, for rotating the one of passage 232 and outer sleeve 240 relative to the other. Alternatively, the actuator may be coupled, for example, to a lower end of passage 232, with passage 232 being slidably received by mixing chamber 181, for rotating passage 232 relative to sleeve 240. The actuator may include a knob or other protrusion 248 that may be accessible to a user. Protrusion 244 may, for example, extend through, and slide, within a slot 250 at a surface of mixing chamber 181.
Rotation of passage 232 and/or outer sleeve 240 may cause perforations 236 and 244 to become aligned or unaligned. For example, passage 232 may be fixed (non-rotatable), and outer sleeve 240 may be movable (rotatable). In a first (closed) configuration as shown in
In a second (open) configuration, as shown in
There may be numerous intermediate configurations of passage 232 and outer sleeve 240. For example, in certain configurations, perforations 244 and perforations 236 may partially align so that some fluidized powdered agent 54 may pass through perforations 244 and 236 to passage 232, but flow of fluidized powdered agent 54 is less than in an open configuration. Perforations 236 and 244 may be arranged to allow for a wide variety of configurations.
The features depicted in
Powder chamber 272 may include any suitable receptacle for holding powdered agent 54. Powder chamber 272 may include, for example, a substantially rigid vessel, such as a bottle. Powder chamber 272 may be fixedly attached or removably attached to any suitable chassis, such as chassis 12 or any other aforementioned chassis. In
As shown in
Assembly 270 may include a passage 282 for directing pressurized gas. Flow of pressurized gas through passage 282 or any other passage described herein may be controlled by metering orifices located in any suitable position. Mixing chamber 274 may also include an opening 286 and a passage 288, wherein pressurized fluid from passage 282 may direct fluidized powdered agent 54 to opening 286 and out of mixing chamber 274, or may bypass powdered agent 54 so only pressurized fluid is emitted from opening 286.
A portion of powder chamber 272 such as a top portion of powder chamber 272 may include an opening 292 (see
When assembly 270 is in an open position as shown in
Assembly 270 may also include passage 300. Passage 300 may include a top opening 302. Passage 300 may be in fluid connection with passage 288. Passage 300 may have a longitudinal axis which is coaxial with, or parallel to, a longitudinal axis of powder chamber 272. Powder chamber 272 may also include a protrusion 304 extending downwardly from a top portion of an outer wall 306. Passage 294 may extend through protrusion 304. For example, passage 294 may be parallel to or coaxial with a longitudinal axis of protrusion 304. Protrusion 304 may have a lower portion 310 with a cross section narrower than opening 302. Protrusion 304 may taper so that an upper portion 312 of protrusion 304 has a cross section wider than opening 302. Protrusion 304 may be aligned with passage 300 so that lower portion 310 of protrusion 304 may enter passage 300 via opening 302, thereby plugging opening 302, either partially or fully depending on the depth of insertion of lower portion 310 into passage 300, to put assembly 270 in a closed position (see
It also is contemplated that assembly 270 may have a plurality of open positions that allow different levels of flow of fluidized powdered agent 54 through passage 300. For example, the greater the distance between protrusion 304 and opening 302, the greater the flow of fluidized powdered agent 154 into opening 302. Decreasing the distance may reduce the flow, while still allowing flow at the reduced level.
One or more curved surfaces a top portion of powder chamber 272, in conjunction with the tapering surfaces of protrusion 304, may funnel or otherwise facilitate flow of fluidized powder agent 54 toward a central longitudinal axis of powder chamber 272, and toward opening 302 of passage 300. Side walls of powder chamber 272 may be tapered, such that powder chamber gets narrower as it extends upward, to help direct fluidized powder agent 54 into passage 300.
Assembly 270 may also include a fluid randomizer 320 such as fluid randomizer 220 as described with regard to
In one example, bypass passage 290 may be configured so that it is sufficiently narrow or otherwise occlusive so that pressurized air will not flow through bypass passage 290 so long as slot 308 is not blocked. Because pressurized gas may more easily flow through opening than bypass passage 290, no or essentially no gas or only a small amount of gas may flow through bypass passage 290 so long as pressurized gas and/or fluidized powdered agent 54 are able to exit the powder chamber 272 via slot 308 and/or opening 302. If slot 308 and opening 302 are both blocked, then pressurized gas may seek the path of least resistance and pass through bypass passage 290. In other words, pressurized gas may only flow through bypass passage 290 at all or in an appreciable amount if slot 308 and opening 302 are blocked, rendering bypass passage 290 the path of least resistance. Powdered agent 54 will not flow in such a configuration. A closed position allowing the passage of pressurized gas but not of powdered agent may be desirable, for example, for administering pressurized gas inside a body of a patient, prevent bodily fluids from entering apparatus 270 through its distal end/tip, and/or flushing out apparatus 270.
Similar to the configuration shown in
Assembly 270 may alternatively or additionally make use of any of the features described with regard to
While principles of the present disclosure are described herein with reference to illustrative examples for particular applications, it should be understood that the disclosure is not limited thereto. Those having ordinary skill in the art and access to the teachings provided herein will recognize additional modifications, applications, and substitution of equivalents all fall within the scope of the examples described herein. Accordingly, the invention is not to be considered as limited by the foregoing description.
This application claims the benefit of priority from U.S. Provisional Application No. 62/624,417, filed on Jan. 31, 2018, which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
471854 | Howard | Mar 1892 | A |
881238 | Hasbrouck | Mar 1908 | A |
1145520 | Smith | Jul 1915 | A |
1599959 | Buheiji | Sep 1926 | A |
1732566 | McKendrick | Oct 1929 | A |
2151418 | Bolté | Mar 1939 | A |
2185927 | Shelanski | Jun 1940 | A |
2478715 | Schmitt | Aug 1949 | A |
2623519 | Cohen | Dec 1952 | A |
3669113 | Altounyan et al. | Jun 1972 | A |
3940061 | Gimple et al. | Feb 1976 | A |
4184258 | Barrington et al. | Jun 1980 | A |
4427450 | Kostansek | Jan 1984 | A |
4457329 | Werley et al. | Jul 1984 | A |
4806167 | Raythatha | Feb 1989 | A |
5215221 | Dirksing | Jun 1993 | A |
5231983 | Matson et al. | Aug 1993 | A |
5273531 | Knoepfler | Dec 1993 | A |
5312331 | Kneopfler | May 1994 | A |
5312333 | Churinetz et al. | May 1994 | A |
5366122 | Guentert et al. | Nov 1994 | A |
5445612 | Ferakura et al. | Aug 1995 | A |
5470311 | Setterstrom et al. | Nov 1995 | A |
5884621 | Matsugi et al. | Mar 1999 | A |
5951531 | Ferdman et al. | Sep 1999 | A |
5989215 | Delmotte et al. | Nov 1999 | A |
6003512 | Gerde | Dec 1999 | A |
6484750 | Foos et al. | Nov 2002 | B1 |
6554022 | Wakeman | Apr 2003 | B2 |
6589087 | Mackal et al. | Jul 2003 | B2 |
6684917 | Zhu et al. | Feb 2004 | B2 |
6708712 | Wakeman | Mar 2004 | B2 |
6716190 | Glines et al. | Apr 2004 | B1 |
6799571 | Hughes et al. | Oct 2004 | B1 |
7178547 | Mackal | Feb 2007 | B2 |
7311270 | Kapila | Dec 2007 | B2 |
7334598 | Hollars | Feb 2008 | B1 |
7361300 | Kelly et al. | Apr 2008 | B2 |
7427607 | Suzuki | Sep 2008 | B2 |
7455248 | Kablik et al. | Nov 2008 | B2 |
7461649 | Gamard et al. | Dec 2008 | B2 |
7544177 | Gertner | Jun 2009 | B2 |
7563299 | Baptista da Costa et al. | Jul 2009 | B2 |
7673647 | Mackal | Mar 2010 | B2 |
7841338 | Dunne et al. | Nov 2010 | B2 |
7892205 | Palasis et al. | Feb 2011 | B2 |
7921874 | Tekulve et al. | Apr 2011 | B2 |
8037880 | Zhu et al. | Oct 2011 | B2 |
8097071 | Burgess et al. | Jan 2012 | B2 |
8118777 | Ducharme et al. | Feb 2012 | B2 |
8269058 | McCarthy et al. | Sep 2012 | B2 |
8313474 | Campbell et al. | Nov 2012 | B2 |
8360276 | Rogier et al. | Jan 2013 | B2 |
8361054 | Ducharme et al. | Jan 2013 | B2 |
8496189 | Lomond et al. | Jul 2013 | B2 |
20130218 | Kubo | Aug 2013 | |
8673065 | Burgess et al. | Mar 2014 | B2 |
8721582 | Ji | May 2014 | B2 |
8728032 | Ducharme et al. | May 2014 | B2 |
8741335 | McCarthy | Jun 2014 | B2 |
8827980 | Ji | Sep 2014 | B2 |
8910627 | Iwatschenko et al. | Dec 2014 | B2 |
8951565 | McCarthy | Feb 2015 | B2 |
9028437 | Ott et al. | May 2015 | B2 |
9089658 | Dunne et al. | Jul 2015 | B2 |
9101744 | Ducharme | Aug 2015 | B2 |
9107668 | Melsheimer et al. | Aug 2015 | B2 |
9132206 | McCarthy | Sep 2015 | B2 |
9204957 | Gregory et al. | Dec 2015 | B2 |
9205170 | Lucchesi et al. | Dec 2015 | B2 |
9205207 | Ji | Dec 2015 | B2 |
9205240 | Greenhalgh | Dec 2015 | B2 |
9308584 | Burgess et al. | Apr 2016 | B2 |
9310812 | Costle et al. | Apr 2016 | B2 |
9375533 | Ducharme et al. | Jun 2016 | B2 |
9492646 | Hoogenakker et al. | Nov 2016 | B2 |
9517976 | Mackal | Dec 2016 | B2 |
9545490 | Iwatschenko et al. | Jan 2017 | B2 |
9555185 | Foster et al. | Jan 2017 | B2 |
9629966 | Ji | Apr 2017 | B2 |
9636470 | Pohlmann et al. | May 2017 | B2 |
9707359 | Kubo | Jul 2017 | B2 |
9713682 | Eistetter et al. | Jul 2017 | B2 |
9717897 | Rogier | Aug 2017 | B2 |
9821084 | Diegelmann et al. | Nov 2017 | B2 |
9839772 | Ducharme | Dec 2017 | B2 |
9839774 | Bonaldo | Dec 2017 | B2 |
9846439 | Carman et al. | Dec 2017 | B2 |
9867931 | Gittard | Jan 2018 | B2 |
9976660 | Stanton et al. | May 2018 | B2 |
10004690 | Lee et al. | Jun 2018 | B2 |
10010705 | Greenhalgh et al. | Jul 2018 | B2 |
10017231 | Fawcett, Jr. | Jul 2018 | B2 |
10036617 | Mackal | Jul 2018 | B2 |
10065004 | Eder et al. | Sep 2018 | B2 |
10173019 | Kaufmann et al. | Jan 2019 | B2 |
10384049 | Stanton et al. | Aug 2019 | B2 |
10463811 | Lee et al. | Nov 2019 | B2 |
10507293 | Goodman et al. | Dec 2019 | B2 |
10646706 | Rogier | May 2020 | B2 |
10730595 | Fawcett | Aug 2020 | B2 |
10751523 | Rogier | Aug 2020 | B2 |
10806853 | Gittard | Oct 2020 | B2 |
10850814 | Fawcett | Dec 2020 | B2 |
10994818 | Hernandez | May 2021 | B2 |
20040107963 | Finlay et al. | Jun 2004 | A1 |
20040249359 | Palasis et al. | Dec 2004 | A1 |
20050121025 | Gamard et al. | Jun 2005 | A1 |
20050147656 | McCarthy et al. | Jul 2005 | A1 |
20050220721 | Kablik et al. | Oct 2005 | A1 |
20060004314 | McCarthy et al. | Jan 2006 | A1 |
20060213514 | Price et al. | Sep 2006 | A1 |
20070056586 | Price et al. | Mar 2007 | A1 |
20070066920 | Hopman et al. | Mar 2007 | A1 |
20070066924 | Hopman et al. | Mar 2007 | A1 |
20070082023 | Hopman et al. | Apr 2007 | A1 |
20070125375 | Finlay et al. | Jun 2007 | A1 |
20070151560 | Price et al. | Jul 2007 | A1 |
20070083137 | Hopman et al. | Aug 2007 | A1 |
20070199824 | Hoerr et al. | Aug 2007 | A1 |
20080021374 | Kawata | Jan 2008 | A1 |
20080287907 | Gregory et al. | Nov 2008 | A1 |
20090101144 | Gamard et al. | Apr 2009 | A1 |
20090155342 | Diegemann et al. | Jun 2009 | A1 |
20090281486 | Ducharme | Nov 2009 | A1 |
20100121261 | Kablik et al. | May 2010 | A1 |
20100305505 | Ducharme | Dec 2010 | A1 |
20110073200 | Overvaag et al. | Mar 2011 | A1 |
20110274726 | Guo et al. | Nov 2011 | A1 |
20110308516 | Price et al. | Dec 2011 | A1 |
20130218072 | Kubo | Aug 2013 | A1 |
20140271491 | Gittard et al. | Sep 2014 | A1 |
20150094649 | Gittard | Apr 2015 | A1 |
20150125513 | McCarthy | May 2015 | A1 |
20160375202 | Goodman et al. | Dec 2016 | A1 |
20170106181 | Bonaldo et al. | Apr 2017 | A1 |
20170119980 | Eder | May 2017 | A1 |
20170232141 | Surti et al. | Aug 2017 | A1 |
20170252479 | Ji et al. | Sep 2017 | A1 |
20170296760 | Lee et al. | Oct 2017 | A1 |
20180099088 | Gittard | Apr 2018 | A1 |
20180193574 | Smith et al. | Jul 2018 | A1 |
20180214160 | Hoskins et al. | Aug 2018 | A1 |
20180339144 | Greenhalgh et al. | Nov 2018 | A1 |
20190134366 | Erez et al. | May 2019 | A1 |
20190217315 | Maguire et al. | Jul 2019 | A1 |
20190232030 | Pic et al. | Aug 2019 | A1 |
20210024187 | Fawcett et al. | Jan 2021 | A1 |
20210069485 | Rogier | Mar 2021 | A1 |
Number | Date | Country |
---|---|---|
101401956 | Nov 2012 | CN |
60215438 | Aug 2007 | DE |
1 821 083 | Aug 2007 | EP |
3052168 | Nov 2019 | EP |
H07118305 | May 1995 | JP |
03013552 | Feb 2003 | WO |
2004066806 | Aug 2004 | WO |
2005062896 | Jul 2005 | WO |
2006071649 | Jul 2006 | WO |
2006088912 | Aug 2006 | WO |
2008033462 | Mar 2008 | WO |
2009061409 | May 2009 | WO |
2015050814 | Apr 2015 | WO |
2018157772 | Sep 2018 | WO |
Entry |
---|
Bridevaux, Pierre-Olivier, et al. “Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.” European Respiratory Journal 38.4 (2011): 770-773. |
Giday, Samuel, et al. “Safety analysis of a hemostatic powder in a porcine model of acute severe gastric bleeding.” Digestive diseases and sciences 58.12 (2013): 3422-3428. |
Giday, Samuel A., et al. “A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model.” Gastrointestinal Endoscopy 69.5 (2009): AB133. |
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296-299. |
Regalia, Kristen, et al. “Hemospray in Gastrointestinal Bleeding.” Practical Gastroenterology. Endoscopy: Opening New Eyes, ser. 8, May 2014, pp. 13-24. 8. |
Cook Medical. Hemospray Endoscopic Hemostat, COOK, 2014. (7 pages, in English). |
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v1”, Cook Medical, 2012. |
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v2”, Cook Medical, 2013. |
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v3”, Cook Medical, 2014. |
Aslanian, Harry R., and Loren Laine. “Hemostatic powder spray for GI bleeding.” Gastrointestinal endoscopy 77.3 (2013): 508-510. |
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296-299. via ResearchGate. |
RETSCH GmbH Haan. Sieve Analysis: Taking a Close Look at Quality, An Expert Guide to Particle Size Analysis. 2015. (56 pages, in English). |
Micromeritics. Density Analysis, 2001. (6 pages, in English). |
Micromeritics. “Application Note: Bulk and Skeletal Density Computations for the AutoPore.” May 2012. (3 pages, in English). |
Arefnia, Ali, et al. “Comparative Study on the Effect of Tire-Derived Aggregate on Specific Gravity of Kaolin.” Electronic Journal of Geotechnical Engineering 18 (2013): 335-44. |
Kesavan, Jana, et al. “Density Measurements of Materials Used in Aerosol Studies”. Edgewood Chemical Biological Center Aberdeen Proving Ground MD, 2000. |
Number | Date | Country | |
---|---|---|---|
20190232030 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
62624417 | Jan 2018 | US |